Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 110 Carcinoma, Non-Small-Cell Lung 63 Lung Neoplasms 27 Hodgkin Disease 14 Lymphoma 10 Neoplasm Metastasis 9 Triple Negative Breast Neoplasms 8 Neoplasms 8 Recurrence 7 Prostatic Neoplasms 7 Small Cell Lung Carcinoma 5 Sarcoma 5 Rhabdomyosarcoma 5 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Adenocarcinoma of Lung 4 Ovarian Neoplasms 3 NSCLC 3 Mesothelioma, Malignant 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Esophageal Squamous Cell Carcinoma 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locally Advanced/ Metastatic NSCLC × Vinorelbine × Clear all

NCT04208854 2019-12-26

VINORELBINA

International Group of Endovascular Oncology

Locally Advanced/ Metastatic NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡